Consideration of comorbidity in cancer treatment decision-making in multidisciplinary team meetings
the ONA take:
Comorbidity is very common among patients with cancer. Yet little is known about how comorbidity is factored into treatment decision making for these patients.
Treatment decisions are increasingly made within the context of multidisciplinary team meetings (MDTs). A systematic literature review was conducted to determine if and how comorbidity influences MDT decision-making.
The review included 21 original studies. Findings demonstrate that a lack of information on comorbidity impedes the ability to make treatment recommendations as well as to implement those recommendations.
Adjustments to recommended treatment due to comorbidity tends to result in a more conservative approach, despite evidence that treatments are tolerated and effective.
The review concludes that further research is needed to assist MDTs in appropriately addressing comorbidity in their treatment decisions, which can improve outcomes for cancer patients with comorbidities.
Little is known about how comorbidity is factored into treatment decision making for these patients.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|